Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort studyBritish Journal of Surgery, 2021-09, Vol.108 (9), p.1056-1063 [Peer Reviewed Journal]2021. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://academic.oup.com/journals/pages/coronavirus . ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0007-1323 ;ISSN: 1365-2168 ;EISSN: 1365-2168 ;DOI: 10.1093/bjs/znab101Digital Resources/Online E-Resources |
|
2 |
Material Type: Article
|
Pathological sequelae of long-haul COVIDNature immunology, 2022-02, Vol.23 (2), p.194-202 [Peer Reviewed Journal]2022. Springer Nature America, Inc. ;Springer Nature America, Inc. 2022. ;ISSN: 1529-2908 ;EISSN: 1529-2916 ;DOI: 10.1038/s41590-021-01104-y ;PMID: 35105985Full text available |
|
3 |
Material Type: Article
|
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019Clinical infectious diseases, 2020-11, Vol.71 (16), p.2027-2034 [Peer Reviewed Journal]The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. 2020 ;The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. ;ISSN: 1058-4838 ;EISSN: 1537-6591 ;DOI: 10.1093/cid/ciaa344 ;PMID: 32221519Full text available |
|
4 |
Material Type: Article
|
Response to SARS-CoV-2 vaccination in patients after hematopoietic cell transplantation and CAR T-cell therapyBlood, 2021-10, Vol.138 (14), p.1278-1281 [Peer Reviewed Journal]2021 American Society of Hematology ;2021 by The American Society of Hematology 2021 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2021012769 ;PMID: 34339501Full text available |
|
5 |
Material Type: Article
|
Attitudes Toward a Potential SARS-CoV-2 Vaccine: A Survey of U.S. AdultsAnnals of Internal Medicine, 2020-12 [Peer Reviewed Journal]2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://annals.org/aim/pages/conditions-of-use ;DOI: 10.7326/M20-3569Digital Resources/Online E-Resources |
|
6 |
Material Type: Article
|
Viral targets for vaccines against COVID-19Nature reviews. Immunology, 2021-02, Vol.21 (2), p.73-82 [Peer Reviewed Journal]COPYRIGHT 2021 Nature Publishing Group ;Springer Nature Limited 2020. ;Springer Nature Limited 2020 ;ISSN: 1474-1733 ;EISSN: 1474-1741 ;DOI: 10.1038/s41577-020-00480-0 ;PMID: 33340022Full text available |
|
7 |
Material Type: Article
|
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2Cell, 2021-04, Vol.184 (9), p.2332-2347.e16 [Peer Reviewed Journal]2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;2021 Elsevier Inc. 2021 Elsevier Inc. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2021.03.028 ;PMID: 33761326Full text available |
|
8 |
Material Type: Article
|
Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19New England Journal of Medicine, 2021-06, Vol.384 (23), p.2259-2261 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2103916 ;PMID: 33822494Digital Resources/Online E-Resources |
|
9 |
Material Type: Article
|
Integrated analysis of multimodal single-cell dataCell, 2021-06, Vol.184 (13), p.3573-3587.e29 [Peer Reviewed Journal]2021 The Authors ;Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved. ;2021 The Authors 2021 ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2021.04.048 ;PMID: 34062119Full text available |
|
10 |
Material Type: Article
|
COVID-19 vaccines: where we stand and challenges aheadCell death and differentiation, 2021-02, Vol.28 (2), p.626-639 [Peer Reviewed Journal]The Author(s), under exclusive licence to ADMC Associazione Differenziamento e Morte Cellulare 2021. ;The Author(s), under exclusive licence to ADMC Associazione Differenziamento e Morte Cellulare 2021 ;ISSN: 1350-9047 ;EISSN: 1476-5403 ;DOI: 10.1038/s41418-020-00720-9 ;PMID: 33479399Full text available |
|
11 |
Material Type: Article
|
Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern AfricaNature (London), 2022-03, Vol.603 (7902), p.679-686 [Peer Reviewed Journal]2022. The Author(s). ;Copyright Nature Publishing Group Mar 24, 2022 ;The Author(s) 2022 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-022-04411-y ;PMID: 35042229Full text available |
|
12 |
Material Type: Article
|
Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited seraNature medicine, 2021-04, Vol.27 (4), p.620-621 [Peer Reviewed Journal]COPYRIGHT 2021 Nature Publishing Group ;The Author(s), under exclusive licence to Springer Nature America, Inc. part of Springer Nature 2021. ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-021-01270-4 ;PMID: 33558724Full text available |
|
13 |
Material Type: Article
|
Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccinationThe Lancet (British edition), 2021-06, Vol.397 (10292), p.2331-2333 [Peer Reviewed Journal]2021 Elsevier Ltd ;2021. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)01290-3 ;PMID: 34090624Full text available |
|
14 |
Material Type: Article
|
Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19Nature immunology, 2020-12, Vol.21 (12), p.1506-1516 [Peer Reviewed Journal]COPYRIGHT 2020 Nature Publishing Group ;The Author(s), under exclusive licence to Springer Nature America, Inc. 2020. ;ISSN: 1529-2908 ;EISSN: 1529-2916 ;DOI: 10.1038/s41590-020-00814-z ;PMID: 33028979Full text available |
|
15 |
Material Type: Article
|
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasionNature (London), 2021-11, Vol.599 (7883), p.114-119 [Peer Reviewed Journal]2021. The Author(s). ;Copyright Nature Publishing Group Nov 4, 2021 ;The Author(s) 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03944-y ;PMID: 34488225Full text available |
|
16 |
Material Type: Article
|
Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron InfectionNew England Journal of Medicine, 2022-02, Vol.386 (5), p.492-494 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2119358 ;PMID: 34965337Digital Resources/Online E-Resources |
|
17 |
Material Type: Article
|
Distinct immunological signatures discriminate severe COVID-19 from non-SARS-CoV-2-driven critical pneumoniaImmunity (Cambridge, Mass.), 2021-07, Vol.54 (7), p.1578-1593.e5 [Peer Reviewed Journal]2021 The Author(s) ;Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved. ;2021. The Author(s) ;Distributed under a Creative Commons Attribution 4.0 International License ;2021 The Author(s) 2021 ;ISSN: 1074-7613 ;EISSN: 1097-4180 ;DOI: 10.1016/j.immuni.2021.05.002 ;PMID: 34051147Full text available |
|
18 |
Material Type: Article
|
Plasma Neutralization of the SARS-CoV-2 Omicron VariantNew England Journal of Medicine, 2022-02, Vol.386 (6), p.599-601 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2119641 ;PMID: 35030645Digital Resources/Online E-Resources |
|
19 |
Material Type: Article
|
The T cell immune response against SARS-CoV-2Nature immunology, 2022-02, Vol.23 (2), p.186-193 [Peer Reviewed Journal]2022. Springer Nature America, Inc. ;Springer Nature America, Inc. 2022. ;ISSN: 1529-2908 ;EISSN: 1529-2916 ;DOI: 10.1038/s41590-021-01122-w ;PMID: 35105982Full text available |
|
20 |
Material Type: Article
|
SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent PersonsNew England Journal of Medicine, 2022-02, Vol.386 (7), p.698-700 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2022 Massachusetts Medical Society. All rights reserved. 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2119236 ;PMID: 35021005Digital Resources/Online E-Resources |